Behbahani Ali

Arcellx, Inc. · Director

Behbahani Ali is listed in public filings as director. This Behbahani Ali insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Arcellx, Inc. (ACLX), Korro Bio, Inc. (KRRO), Adaptimmune Therapeutics plc (ADAPY), Monte Rosa Therapeutics, Inc. (GLUE), and CRISPR Therapeutics AG-Common Shares (CRSP). Investors use Behbahani Ali's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Arcellx, Inc.ACLX$09.2k sharesOtherApr 28, 2026$584.2K9.2k shares$63.68--
Arcellx, Inc.ACLX$011.5k sharesOtherApr 28, 2026$434.8K11.5k shares$37.94--
Arcellx, Inc.ACLX$08k sharesOtherApr 28, 2026$411.0K8k shares$51.30--
Arcellx, Inc.ACLX$02.7k sharesOtherApr 28, 2026$311.2K2.7k shares$115.00--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Korro Bio, Inc.KRRO$14M1.3M sharesGrant / ExerciseMar 10, 2026$2.3M207.1k shares$11.11--
Korro Bio, Inc.KRRO$243242.9k sharesGrant / ExerciseMar 10, 2026$243242.9k shares$0.001--
Adaptimmune Therapeutics plcADAPY$014.7M sharesSellAug 18, 2025$176.1K14.7M shares$0.012--
Adaptimmune Therapeutics plcADAPY$161k14.7M sharesSellAug 15, 2025$53.1K4.8M shares$0.011--
Arcellx, Inc.ACLX--1.9k sharesOtherAug 12, 2025Disclosure amount unavailable1.6k shares----
Arcellx, Inc.ACLX--2.7k sharesOtherAug 12, 2025Disclosure amount unavailable2.6k shares----
Monte Rosa Therapeutics, Inc.GLUE$151k30.7k sharesGrant / ExerciseJun 13, 2025$150.7K30.7k shares$4.91--
Korro Bio, Inc.KRRO$89k6k sharesGrant / ExerciseJun 11, 2025$89.4K6k shares$14.87--
CRISPR Therapeutics AG-Common SharesCRSP$501k13k sharesGrant / ExerciseJun 5, 2025$501.4K13k shares$38.57--
Nkarta, Inc.NKTX$84k46k sharesGrant / ExerciseJun 5, 2025$84.2K46k shares$1.83--
Arcellx, Inc.ACLX$584k9.2k sharesGrant / ExerciseMay 29, 2025$584.2K9.2k shares$63.68--
Trevi Therapeutics, Inc.TRVI$01.9M sharesOtherApr 17, 2025$2.5M1.9M shares$1.37--
Adaptimmune Therapeutics plcADAPY$183k1.1M sharesGrant / ExerciseJul 1, 2024$183.2K1.1M shares$0.16--
Nkarta, Inc.NKTX$140k22.5k sharesGrant / ExerciseJun 13, 2024$140.2K22.5k shares$6.23--
Monte Rosa Therapeutics, Inc.GLUE$92k22.1k sharesGrant / ExerciseJun 12, 2024$91.9K22.1k shares$4.16--
Korro Bio, Inc.KRRO$219k5.2k sharesGrant / ExerciseJun 11, 2024$219.0K5.2k shares$42.19--
Behbahani Ali | TradingNote